- Member Benefits
- Manage your personalised Watchlist.
- Set up an online Virtual Portfolio.
- Participate in Share Chat.
- See more trades and director dealings.
- Play the Fantasy Share Trading Game.
Share:
HomeShare PricesStock PickerFinancial DiaryUK IndicesUK Industry SectorsCompany LookupShare RisersShare FallersBroker RatingsFinance GlossarySMS ServicesShare ChatFinance NewsBlogsLive PricesShares BookshopFinance ToolsMembers
Latest Share Chat
Skyepharma Share News (SKP)
Share News for Skyepharma (SKP)
| Share Price: 50.50 | Bid: 50.00 | Ask: 54.00 | Change: 0.00 (0.00%) |  | ||||||
| ||||||||||
SkyePharma says a phase III efficacy Flutiform study meets goals
LONDON (Thomson Financial) - Drug delivery specialist SkyePharma plc says that a late-stage study of its asthma treatment Flutiform has met its[30 Apr '08]
SkyePharma agrees Flutiform exclusive licence deal with Kyorin in Japan UPDATE
(Adds CEO comments, analyst reaction, live share price) LONDON (Thomson Financial) - SkyePharma plc. has signed an exclusive development, di[22 Apr '08]
SkyePharma agrees Flutiform exclusive licence deal with Kyorin in japan
LONDON (Thomson Financial) - SkyePharma plc. has signed an exclusive development, distribution and license agreement with Kyorin Pharmaceutical[22 Apr '08]
SkyePharma reveals positive Flutiform results from paediatric study UPDATE
(adds detail, CEO, analyst comment) LONDON (Thomson Financial) - UK pharmaceutical group SkyePharma Plc. announced positive results for its[15 Apr '08]
SkyePharma reveals positive Flutiform results from paediatric study
LONDON (Thomson Financial) - UK pharmaceutical group SkyePharma Plc. announced positive results for its asthma drug Flutiform after a paediatric[15 Apr '08]
SkyePharma FY pretax loss 23.7 mln stg, renegotiate bonds by year end UPDATE
(Recasts, adds company comment) LONDON (Thomson Financial) - UK drug delivery specialist SkyePharma said it would like to complete renegotia[27 Mar '08]
SkyePharma FY pretax loss 23.7 mln stg, goal to renegotiate bonds UPDATE
(Adds initial analyst comment) LONDON (Thomson Financial) - UK drug delivery specialist SkyePharma says that pretax loss for the full year w[27 Mar '08]
Skyepharma FY pretax loss 23.7 mln stg vs 19.3 mln, goal to renegotiate bonds
LONDON (Thomson Financial) - UK drug delivery specialist SkyePharma says that pretax loss for the full year widened to 23.7 mln stg vs 19.3 mln,[27 Mar '08]
